ICN Gets 54% Stake in Bulgarian Company
- Share via
ICN Pharmaceuticals Inc., the biggest drug maker in Eastern Europe, bought 54% of Bulgaria’s Biovet, which produced pharmaceutical products for animals, said a spokesman for the Bulgarian government’s Privatization Agency, the body responsible for asset sales.
Costa Mesa-based ICN will pay $13.6 million for the stake and will invest $10 million over five years in the new company, to be called ICN Biovet. ICN also plans to set up a marketing center in the Bulgarian capital Sofia to target overseas markets.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
